Incyte
INCY
#1201
Rank
NZ$32.35 B
Marketcap
NZ$162.55
Share price
-1.43%
Change (1 day)
31.13%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2024: NZ$0.53 Billion

According to Incyte's latest financial reports the company's current earnings are NZ$4.81 Billion. In 2024 the company made an earning of NZ$0.53 Billion a decrease over its 2023 earnings that were of NZ$1.41 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2024

Annual earnings

Year Earnings Change
2024NZ$0.53 B-62.04%
2023NZ$1.41 B57.66%
2022NZ$0.89 B-7.24%
2021NZ$0.96 B-345.65%
2020-NZ$0.4 Billion-147.7%
2019NZ$0.82 B322.02%
2018NZ$0.19 B-136.94%
2017-NZ$0.53 Billion-390.76%
2016NZ$0.18 B1322%
2015NZ$12.79 M-115.56%
2014-NZ$82.26 Million-41.4%
2013-NZ$0.15 Billion87.67%
2012-NZ$74.8 Million-74.9%
2011-NZ$0.3 Billion843.59%
2010-NZ$31.58 Million-88.68%
2009-NZ$0.28 Billion1.37%
2008-NZ$0.28 Billion86.16%
2007-NZ$0.15 Billion17.64%
2006-NZ$0.13 Billion-28.62%
2005-NZ$0.18 Billion-36.1%
2004-NZ$0.28 Billion-2.03%
2003-NZ$0.29 Billion22.26%
2002-NZ$0.24 Billion-27.39%
2001-NZ$0.32 Billion198.72%
2000-NZ$0.11 Billion132.2%
1999-NZ$45.67 Million-556.86%
1998NZ$9.99 M-37.23%
1997NZ$15.92 M-259.32%
1996-NZ$10 Million-45.87%
1995-NZ$18.47 Million-9.17%
1994-NZ$20.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.70 B 929.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$20.08 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.12 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.96 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-NZ$77.81 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-NZ$49.21 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$94.12 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA